Home › NDC Lookup › RxCUI directory › RxCUI 2664894

Meropenem 2000 MG Injection — RxCUI 2664894

RxNorm drug concept · Semantic clinical drug
RxCUI 2664894 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2664894
Official nameMeropenem 2000 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmeropenem 2 GM Injection
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)375 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Meropenem Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Meropenem is only available as an intravenous injection — there's no pill form. It's used for serious bacterial infections that need a powerful antibiotic delivered directly into t...
  • Why am I getting an IV antibiotic instead of pills?
  • The most common ones are diarrhea, nausea, headache, and rash — these are usually manageable. The ones to take seriously are a severe allergic reaction (sudden hives, swelling, tro...
  • What side effects should I actually watch out for?
📖 Read our full Meropenem Injection guide →

🕸️ Concept Web — How Meropenem 2000 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Meropenem 2000 MG Injection RxCUI 2664894

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Meropenem 29561
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Meropenem Injection 1722933
    • Meropenem Injectable Product 1165713
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Meropenem 2000 MG 2664893

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Meropenem 2000 MG SCDC · 2664893
  • Meropenem Injection SCDF · 1722933
  • Meropenem Injectable Product SCDG · 1165713

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 2664894 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
44567-0402-06 6 VIAL in 1 CARTON (44567-402-06) / 1 INJECTION, POWDER, FO... Meropenem WG Critical Care, LLC 2023-09-08
72078-0081-06 6 INJECTION in 1 CARTON (72078-081-06) Meropenem Mylan Institutional LLC 2025-07-01
81962-0002-08 6 INJECTION in 1 CARTON (81962-002-08) Meropenem BROOKS STERISCIENCE LIMITED 2025-06-27
Observed labelers: BROOKS STERISCIENCE LIMITED (1) · Mylan Institutional LLC (1) · WG Critical Care, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2183 Inj meropenem (wg crit care) 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.